Reaction Details Report a problem with these data
Target
B-cell lymphoma 6 protein [5-129]
Ligand
BDBM522236
Substrate
n/a
Meas. Tech.
HTRF Assay
IC50
36.3±n/a nM
Citation
 Bellenie, BR; Cheung, KM; Davis, OA; Hoelder, S; Huckvale, R; Lloyd, MG 2-quinolone derived inhibitors of BCL6 US Patent  US11161839 Publication Date 11/2/2021 
Target
Name:
B-cell lymphoma 6 protein [5-129]
Synonyms:
BCL5 | BCL6 | BCL6_HUMAN | BTB domain-containing protein 27 (BCL-6)(5-129) | LAZ3 | ZBTB27 | ZNF51
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14310.07
Organism:
Homo sapiens (Human)
Description:
aa 5-129
Residue:
125
Sequence:
ADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE
  
Inhibitor
Name:
BDBM522236
Synonyms:
US11161839, Example 1u
Type:
Small organic molecule
Emp. Form.:
C25H23ClN8O2
Mol. Mass.:
502.956
SMILES:
CNC(=O)c1cc(Nc2ccc3n(C)c(=O)cc(NC(C)(C)c4ncccn4)c3c2)c(C#N)c(Cl)n1
Structure:
Search PDB for entries with ligand similarity: